How Earnings Reports Can Be Investors’ Crystal Ball
October 21, 2022
Earnings season is once again upon us. It is that time of the quarter where investors get to see what has been going on under the hood of their favorite company throughout the past three ...
Sector Spotlight: Stocks Continue To Chop Along
October 20, 2022
Market Recap For October 20th, 2022 Once again, markets chopped up and down without making much progress in either direction. The close, however, ended on a bearish note. Although it doesn’t seem as such over ...
Moderna (MRNA) Dives Toward Support, Will It Hold?
October 20, 2022
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and ...
